# PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE

Study · id `cardio:ct-nct04601467` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04601467](<https://clinicaltrials.gov/study/NCT04601467>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04601467

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 243 participants.

## Technical summary

Registry record NCT04601467. Randomized; triple masking; primary purpose treatment. Start 2021-07-12 (actual); primary completion 2024-05-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 243 participants (enrolled count; ClinicalTrials.gov record NCT04601467, source copy `cardio:ctgov-nct04601467-2025-04-27`, retrieved 2026-10-31)
- Started: 2021-07-12 (actual) (ClinicalTrials.gov record NCT04601467, source copy `cardio:ctgov-nct04601467-2025-04-27`, retrieved 2026-10-31)
- Primary completion: 2024-05-27 (actual) (ClinicalTrials.gov record NCT04601467, source copy `cardio:ctgov-nct04601467-2025-04-27`, retrieved 2026-10-31)
- Completion: 2024-08-14 (actual) (ClinicalTrials.gov record NCT04601467, source copy `cardio:ctgov-nct04601467-2025-04-27`, retrieved 2026-10-31)
- Countries: New Zealand; Singapore (ClinicalTrials.gov record NCT04601467, source copy `cardio:ctgov-nct04601467-2025-04-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04601467-2025-04-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
- Acronym: PASSIVATE
- Condition: Acute Coronary Syndrome
- Intervention (Drug): AZD5718
- Intervention (Drug): Placebo
- Lead sponsor: National University Heart Centre, Singapore
- Lead sponsor class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY
- Collaborator: University of Otago
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)
- Registry lists this organization as a collaborator: University of Otago (`cardio:org-university-of-otago`)

## Provenance

Content hash: 9615d99d52380dd44ce760890ebf8a4e4d91f337d0511bde959cfb887d6967b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
